SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,472,000 | +36.7% | 667,064 | +34.3% | 0.00% | 0.0% |
| Q2 2017 | $5,464,000 | -21.1% | 496,820 | -29.7% | 0.00% | +100.0% |
| Q1 2017 | $6,924,000 | -17.4% | 706,602 | -8.9% | 0.00% | 0.0% |
| Q4 2016 | $8,382,000 | +109.7% | 776,008 | +99.0% | 0.00% | 0.0% |
| Q3 2016 | $3,997,000 | -28.9% | 390,039 | -9.3% | 0.00% | -50.0% |
| Q2 2016 | $5,618,000 | -1.3% | 430,149 | -16.9% | 0.00% | 0.0% |
| Q1 2016 | $5,693,000 | -29.9% | 517,594 | -41.3% | 0.00% | -33.3% |
| Q4 2015 | $8,116,000 | +28.2% | 882,152 | -3.3% | 0.00% | +50.0% |
| Q3 2015 | $6,333,000 | -1.2% | 912,597 | +39.8% | 0.00% | 0.0% |
| Q2 2015 | $6,412,000 | +86.1% | 653,009 | +68.0% | 0.00% | +100.0% |
| Q1 2015 | $3,445,000 | +5.9% | 388,809 | +4.7% | 0.00% | 0.0% |
| Q4 2014 | $3,253,000 | +27.8% | 371,297 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $2,545,000 | +639.8% | 369,370 | +463.5% | 0.00% | – |
| Q2 2014 | $344,000 | +493.1% | 65,555 | +407.4% | 0.00% | – |
| Q1 2014 | $58,000 | -66.7% | 12,921 | -62.6% | 0.00% | – |
| Q4 2013 | $174,000 | +22.5% | 34,534 | +23.1% | 0.00% | – |
| Q3 2013 | $142,000 | -86.2% | 28,058 | -86.5% | 0.00% | -100.0% |
| Q2 2013 | $1,032,000 | – | 208,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|